An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability

被引:11
|
作者
De Groef, An [1 ,2 ]
Van Kampen, Marijke [1 ,2 ]
Vervloesem, Nele [1 ,2 ]
De Geyter, Sophie [1 ,2 ]
Dieltjens, Evi [1 ,2 ]
Christiaens, Marie-Rose [3 ,4 ]
Neven, Patrick [3 ,5 ]
Geraerts, Inge [1 ,2 ]
Devoogdt, Nele [1 ,2 ]
机构
[1] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium
[3] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium
[4] Univ Leuven, KU Leuven, Dept Surg Oncol, Leuven, Belgium
[5] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
TRIGGER POINTS; PAIN; SURGERY;
D O I
10.1371/journal.pone.0179116
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. Methods 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing was performed. 2) Thirty patients (63% had a mastectomy, 37% breast-conserving surgery and 97% radiotherapy) with myofascial adhesions were evaluated using the developed tool by 2 independent raters. The Weighted Kappa (WK) and the intra-class correlation coefficient (ICC) were calculated. Results 1) The evaluation tool for Myofascial Adhesions in Patients with Breast Cancer (MAP-BC evaluation tool) consisted of the assessment of myofascial adhesions at 7 locations: axillary and breast region scars, musculi pectorales region, axilla, frontal chest wall, lateral chest wall and the inframammary fold. At each location the degree of the myofascial adhesion was scored at three levels (skin, superficial and deep) on a 4-points scale (between no adhesions and very stiff adhesions). Additionally, a total score (0-9) was calculated, i.e. the sum of the different levels of each location. 2) Interrater agreement of the different levels separately was moderate for the axillary and mastectomy scar (WK 0.62-0.73) and good for the scar on the breast (WK > 0.75). Moderate agreement was reached for almost all levels of the non-scar locations. Interrater reliability of the total scores was the highest for the scars (ICC0.82-0.99). At non-scar locations good interrater reliability was reached, except for the inframammary fold (ICC = 0.71). Conclusions The total scores of all locations of the MAP-BC evaluation tool had good to excellent interrater reliability, except for the inframammary fold which only reached moderate reliability.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity
    De Groef, An
    Van Kampen, Marijke
    Moortgat, Peter
    Anthonissen, Mieke
    Van den Kerckhove, Eric
    Christiaens, Marie-Rose
    Neven, Patrick
    Geraerts, Inge
    Devoogdt, Nele
    PLOS ONE, 2018, 13 (03):
  • [2] Translation, Cross-Cultural Adaptation and Validation of the Myofascial Adhesions for Patients after Breast Cancer (MAP-BC) Evaluation Tool: Spanish Version
    Jesus Casuso-Holgado, Maria
    Ostos-Diaz, Beatriz
    Jesus Munoz-Fernandez, Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (07)
  • [3] Development of a Scoring Tool for Chronic Nonbacterial Osteomyelitis Magnetic Resonance Imaging and Evaluation of its Interrater Reliability
    Zhao, Yongdong
    Sato, T. Shawn
    Nielsen, Sabrina M.
    Beer, Meinrad
    Huang, Mingqian
    Iyer, Ramesh S.
    McGuire, Michael
    Anh-Vu Ngo
    Otjen, Jeffrey P.
    Panwar, Jyoti
    Stimec, Jennifer
    Thapa, Mahesh
    Toma, Paolo
    Taneja, Angela
    Gove, Nancy E.
    Ferguson, Polly J.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (05) : 739 - 747
  • [4] Development of an evidence-based fall risk assessment tool and evaluation of interrater reliability and nurses' perceptions of the tool's clarity and usability
    Higaonna, Miki
    Enobi, Maki
    Nakamura, Shizuka
    JAPAN JOURNAL OF NURSING SCIENCE, 2017, 14 (02) : 146 - 160
  • [5] Endometrial evaluation is a very important tool in the management of breast cancer patients
    Berlière, M
    Galant, C
    Charles, A
    Brichard, V
    Piette, P
    Donnez, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S67 - S68
  • [6] Evaluation of inflammatory biomarkers as helping diagnostic tool in patients with breast cancer
    Baskic, Dejan
    Popovic, Suzana
    Bankovic, Dragic
    Arsovic, Aleksandra
    Vukovic, Vuk
    Zelen, Ivanka
    Djurdjevic, Predrag
    CANCER BIOMARKERS, 2014, 14 (06) : 401 - 408
  • [7] Blinded Evaluation of Interrater Reliability of an Operative Competency Assessment Tool for Direct Laryngoscopy and Rigid Bronchoscopy
    Ishman, Stacey L.
    Benke, James R.
    Johnson, Kaalan Erik
    Zur, Karen B.
    Jacobs, Ian N.
    Thorne, Marc C.
    Brown, David J.
    Lin, Sandra Y.
    Bhatti, Nasir
    Deutsch, Ellen S.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (10) : 916 - 922
  • [8] Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer
    Deng, Zhengyi
    Jones, Miranda R.
    Wolff, Antonio C.
    Visvanathan, Kala
    JNCI CANCER SPECTRUM, 2023, 7 (06)
  • [9] Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population
    Vesna, Zadnik
    Mateja, Krajc
    ONKOLOGIJA, 2018, 22 (02) : 6 - 10
  • [10] Further development and evaluation of a breast/ovarian cancer genetics referral screening tool
    Bellcross, Cecelia
    GENETICS IN MEDICINE, 2010, 12 (04) : 240 - 240